Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD
Clinical trial NCT02362191 · TERMINATED
Trial details
- NCT number
- NCT02362191
- Sponsor
- University of North Carolina, Chapel Hill
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.